RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 99 filers reported holding RAPT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,596 | -1.9% | 27,232 | +10.4% | 0.00% | 0.0% |
| Q2 2023 | $461,441 | -22.1% | 24,676 | -23.6% | 0.00% | -50.0% |
| Q1 2023 | $592,540 | +4.0% | 32,291 | +12.2% | 0.00% | 0.0% |
| Q4 2022 | $569,725 | -2.3% | 28,774 | +18.8% | 0.00% | 0.0% |
| Q3 2022 | $583,000 | +47.2% | 24,222 | +11.6% | 0.00% | +100.0% |
| Q2 2022 | $396,000 | -36.8% | 21,701 | -23.9% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | -30.3% | 28,500 | +16.3% | 0.00% | -50.0% |
| Q4 2021 | $900,000 | +18.3% | 24,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $761,000 | +51.6% | 24,500 | +55.1% | 0.00% | +100.0% |
| Q2 2021 | $502,000 | +43.0% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $351,000 | +12.5% | 15,800 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $312,000 | -45.5% | 15,800 | -11.2% | 0.00% | 0.0% |
| Q3 2020 | $573,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
| GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
| Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
| Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
| Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
| Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
| Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
| Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
| BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |